Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "B02" (227)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Aprotinin (B02AB01) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
IP
Trasylol
Flasche(n) à 50 ml
k.A.
Infusion solution: Aprotininum 277.8U. Ph. Eur. / 50ml
Nordic Pharma GmbH
B
FB
G
Alfa1 Antitrypsin (B02AB02) 6 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
V/S
Glassia 20 mg/ml
330.72
380.35
10 %
Infusion solution: Alpha-1-Proteinasi Inhibitor Humanum 1000mg / 50ml
Ideogen AG
B / SL
FB
G
L
IP
V/S
Prolastin-C Liquid 1000
mg/20 ml
20 ml
312.41
361.55
10 %
Infusion solution: Alpha-1-Proteinasi Inhibitor Humanum
OM Pharma Suisse SA
B / SL
FB
G
L
IP
V/S
PP
Respreeza 50 mg/ml à 1 g
2
313.06
362.25
10 %
Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung: Alpha-1-Proteinasi Inhibitor Humanum 1000 mg
CSL Behring AG
B / SL
FB
G
L
IP
V/S
PP
Respreeza 50 mg/ml à 4 g
2
1252.22
1325.80
10 %
Pulver und Lösungsmittel zur Herstellung einer i.v. Infusionslösung: Alpha-1-Proteinasi Inhibitor Humanum 4000 mg
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Prolastin
312.41
361.55
10 %
poudre et solvant pour solution pour perfusion: Alpha-1-Proteinasi Inhibitor Humanum 1 g
OM Pharma Suisse SA
B / SL
FB
G
IP
V/S
Prolastin-C Liquid 4000
mg/80 ml
80 ml
k.A.
Infusion solution: Alpha-1-Proteinasi Inhibitor Humanum
OM Pharma Suisse SA
B
FB
G
Fibrinogen, Human (B02BB01) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
V/S
Haemocomplettan P 1 g
1 g
395.51
446.85
10 %
Dry substance: Fibrinogenum Humanum 1 g
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Haemocomplettan P 2 g
2 g
791.02
852.65
10 %
Dry substance: Fibrinogenum Humanum 2 g
CSL Behring AG
B / SL
FB
G
L
IP
V/S
Fibryga 1g
407.86
459.50
10 %
Pulver und Lösungsmittel zur Herstellung einer Injektions-/Infusionslösung: Fibrinogenum Humanum 1 g
Octapharma AG
B / SL
FB
G
Fibrinogen, Human (B02BC10) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
IP
V/S
TISSEEL 2 ml
2 x 1 ml
k.A.
Injection solution in prefilled syringe: 3 Active Agents
Injection solution in prefilled syringe: Thrombinum Humanum 400-625 U.I./ml
Baxter AG
B
FB
G
IP
V/S
TISSEEL 4 ml
2 x 2 ml
k.A.
Injection solution in prefilled syringe: 3 Active Agents
Injection solution in prefilled syringe: Thrombinum Humanum 1025U.I. / 2ml
Baxter AG
B
FB
G
Combinations (B02BC30) 7 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
IP
V/S
TachoSil
Tüchlein
k.A.
Sponge: 2 Active Agents
Corza Medical GmbH
B
FB
G
IP
V/S
TachoSil
Tüchlein
k.A.
Sponge: 2 Active Agents
Corza Medical GmbH
B
FB
G
IP
V/S
TachoSil
k.A.
Sponge: 2 Active Agents
Corza Medical GmbH
B
FB
G
IP
V/S
TachoSil
2 Tüchlein
k.A.
Sponge: 2 Active Agents
Corza Medical GmbH
B
FB
G
IP
V/S
TachoSil
5 Tüchlein
k.A.
Sponge: 2 Active Agents
Corza Medical GmbH
B
FB
G
IP
V/S
ARTISS 2 ml
2 x 1 ml
k.A.
tiefgefrorene Lösung: 2 Active Agents
tiefgefrorene Lösung: 2 Active Agents
Baxter AG
B
FB
G
IP
V/S
ARTISS 4 ml
2 x 2 ml
k.A.
tiefgefrorene Lösung: 2 Active Agents
tiefgefrorene Lösung: 2 Active Agents
Baxter AG
B
FB
G
Factor Viii Inhibitor Bypassing Activity (B02BD03) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
V/S
Feiba NF 1000 E.
ampoule(s)
1385.25
1462.30
10 %
Injection preparation: Proteinorum Plasmatis Humani Solutio 400-1200 mg
Takeda Pharma AG
B / SL
FB
G
IP
V/S
Feiba NF 2500 E.
ampoule(s)
3460.73
3591.75
k.A.
Injection preparation: Proteinorum Plasmatis Humani Solutio 1000-3000 mg
Takeda Pharma AG
B
FB
G
Coagulation Factor Ix (B02BD04) 27 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
PP
Idelvion 250 IU
250 IE
529.27
584.05
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 500 IU
500 IE
1058.53
1127.10
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 1000 IU
1000 IE
2117.06
2213.15
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Idelvion 2000 IU
2000 IE
4234.12
4385.25
10 %
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
PP
Alprolix 250 IE
Set(s)
317.54
366.85
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 250 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 500 IE
Set(s)
635.08
692.65
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 500 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 1000 IE
Set(s)
1270.16
1344.20
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 1000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 2000 IE
Set(s)
2540.31
2647.40
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 2000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Alprolix 3000 IE
3810.47
3950.60
10 %
Lyophilisate and solvent: Eftrenonacogum Alfa 3000 UI
Swedish Orphan
Biovitrum AG
B / SL
FB
G
L
IP
PP
Idelvion 3500 IU
3500 IE
7409.71
7643.40
10 %
Lyophilisate and solvent: Albutrepenonacogum Alfa 3500 UI
CSL Behring Lengnau AG
B / SL
FB
G
L
IP
V/S
Immunine STIM Plus 600
433.84
486.15
10 %
Lyophilisate and solvent: 2 Active Agents
Takeda Pharma AG
B / SL
FB
G
L
IP
V/S
Immunine STIM Plus 1200
866.95
930.55
10 %
Lyophilisate and solvent: 2 Active Agents
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 500 IE
889.38
953.55
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 500 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 1000 IE
1778.76
1866.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 1000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 2000 IE
3557.52
3691.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 2000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 3000 IE
5336.28
5516.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 3000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
Rixubis 250 IE
Set(s)
163.35
208.65
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 250 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 500 IE
Set(s)
326.70
376.25
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 500 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 1000 IE
Set(s)
653.40
711.45
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 1000 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
Rixubis 2000 IE
Set(s)
1306.80
1381.80
10 %
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 2000 UI
Takeda Pharma AG
B / SL
FB
G
L
IP
BeneFIX 250
Set(s)
178.71
224.40
10 %
Trockensubstanz zur i.v. Injektion: Nonacogum Alfa 250 UI
Pfizer AG
B / SL
FB
G
L
IP
BeneFIX 500
Set(s)
357.42
407.75
10 %
Trockensubstanz zur i.v. Injektion: Nonacogum Alfa 500 UI
Pfizer AG
B / SL
FB
G
L
IP
BeneFIX 1000
Set(s)
714.84
774.45
10 %
Trockensubstanz zur i.v. Injektion: Nonacogum Alfa 1000 UI
Pfizer AG
B / SL
FB
G
L
IP
BeneFIX 2000
Set(s)
1429.68
1507.90
10 %
Trockensubstanz zur i.v. Injektion: Nonacogum Alfa 2000 UI
Pfizer AG
B / SL
FB
G
L
IP
BeneFIX 3000
Set(s)
2098.27
2193.85
10 %
Trockensubstanz zur i.v. Injektion: Nonacogum Alfa 3000 UI
Pfizer AG
B / SL
FB
G
IP
Rixubis 3000 IE
Set(s)
2008.66
2101.95
k.A.
Lyophilisat und Lösungsmittel zur Injektion: Nonacogum Gamma 3000 UI
Takeda Pharma AG
B
FB
G
IP
V/S
Faktor X P Behring 600
I.E.
600 IE
k.A.
Injection preparation: 3 Active Agents
CSL Behring AG
B
FB
G
Coagulation Factor Viia (B02BD08) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
CI
NovoSeven 1 mg
Set(s)
845.41
908.45
10 %
Lyophilisate and solvent: Eptacogum Alfa 1 mg
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
NovoSeven 2 mg
Set(s)
1690.88
1775.90
10 %
Lyophilisate and solvent: Eptacogum Alfa 2 mg
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
NovoSeven 5 mg
Set(s)
4224.20
4375.05
10 %
Lyophilisate and solvent: Eptacogum Alfa 5 mg
Novo Nordisk Pharma AG
B / SL
FB
G
IP
CI
NovoSeven 8 mg
Set(s)
k.A.
Lyophilisate and solvent: Eptacogum Alfa 8 mg
Novo Nordisk Pharma AG
B
FB
G
Etranacogene Dezaparvovec (B02BD16) 4 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Hemgenix 1x10 e13 gc/mL
2687096.87
2757269.20
10 %
CSL Behring AG
A / SL
FB
G
L
IP
CI
Hemgenix 1x10 e13 gc/mL
13
2687096.87
2757269.20
10 %
CSL Behring AG
A / SL
FB
G
L
IP
CI
Hemgenix 1x10 e13 gc/mL
25
2687096.87
2757269.20
10 %
CSL Behring AG
A / SL
FB
G
L
IP
CI
Hemgenix 1x10 e13 gc/mL
37
2687096.87
2757269.20
10 %
CSL Behring AG
A / SL
FB
G
Other Systemic Hemostatics (B02BX) 5 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Alhemo 60 mg/1.5 ml
4223.28
4374.15
10 %
Injektionslösung im Fertigpen: Concizumabum 40mg / 1ml
Novo Nordisk Pharma AG
A / SL
FB
G
L
IP
CI
Alhemo 150 mg/1.5 ml
10558.20
10873.75
10 %
Injektionslösung im Fertigpen: Concizumabum 100mg / 1ml
Novo Nordisk Pharma AG
A / SL
FB
G
L
IP
CI
Hympavzi 150 mg
6669.64
6884.10
10 %
Injektionslösung im Fertigpen: Marstacimabum 150 mg/ml
Pfizer AG
A / SL
FB
G
IP
CI
Alhemo 15 mg/1.5 ml
k.A.
Injektionslösung im Fertigpen: Concizumabum 10mg / 1ml
Novo Nordisk Pharma AG
A
FB
G
IP
CI
Alhemo 300 mg/3 ml
k.A.
Injektionslösung im Fertigpen: Concizumabum 100mg / 1ml
Novo Nordisk Pharma AG
A
FB
G
Etamsylate (B02BX01) 4 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
IP
CI
Dicynone 250
4 ampoule(s)
4.16
13.75
10 %
Injection solution: Etamsylatum 250 mg
OM Pharma SA
B / SL
FB
G
IP
CI
Dicynone 500
20 Capsule(s)
k.A.
Capsules: Etamsylatum 500 mg
OM Pharma SA
B
FB
G
IP
CI
Dicynone 250
100 ampoule(s)
208.05
k.A.
Injection solution: Etamsylatum 250 mg
OM Pharma SA
B
FB
G
IP
CI
Dicynone 500
60 Capsule(s)
k.A.
Capsules: Etamsylatum 500 mg
OM Pharma SA
B
FB
G
Eltrombopag (B02BX05) 35 products
WHO-DDD
DrugBank.ca
Page 1 of 3:
1
2
3
>>
L
IP
CI
Revolade 12,5 mg
14
249.49
287.75
10 %
Coated tablets: Eltrombopagum 12.5 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 25 mg
14 Tablet(s)
498.97
543.70
10 %
Coated tablets: Eltrombopagum 25 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 25 mg
28 Tablet(s)
997.94
1071.00
10 %
Coated tablets: Eltrombopagum 25 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 50 mg
14 Tablet(s)
997.94
1071.00
10 %
Coated tablets: Eltrombopagum 50 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 50 mg
28 Tablet(s)
1995.87
2125.60
10 %
Coated tablets: Eltrombopagum 50 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Revolade 75 mg
28
2993.81
3180.20
10 %
Coated tablets: Eltrombopagum 75 mg
Novartis Pharma
Schweiz AG
A / SL / SO
FB
G
L
IP
CI
Eltrombopag-Mepha 25 mg
14
249.49
287.75
10 %
Coated tablets: Eltrombopagum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 25 mg
28
498.97
559.10
10 %
Coated tablets: Eltrombopagum 25 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 50 mg
14
498.97
559.10
10 %
Coated tablets: Eltrombopagum 50 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 50 mg
28
997.94
1101.75
10 %
Coated tablets: Eltrombopagum 50 mg
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Eltrombopag-Mepha 75 mg
28
1496.91
1644.40
10 %
Coated tablets: Eltrombopagum 75 mg
Mepha Pharma AG
A / SL / SG
FB
G
Eltrombopag Accord 12.5 mg
14
k.A.
Coated tablets: Eltrombopagum 12.5 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 25 mg
14
k.A.
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 25 mg
28
k.A.
Coated tablets: Eltrombopagum 25 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 50 mg
14
k.A.
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 50 mg
28
k.A.
Coated tablets: Eltrombopagum 50 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Accord 75 mg
28
k.A.
Coated tablets: Eltrombopagum 75 mg
Accord Healthcare AG
A
FB
G
Eltrombopag Spirig HC 25 mg
7
k.A.
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Spirig HC 25 mg
14
k.A.
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Spirig HC 25 mg
28
k.A.
Coated tablets: Eltrombopagum 25 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Spirig HC 50 mg
14
k.A.
Coated tablets: Eltrombopagum 50 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Spirig HC 50 mg
28
k.A.
Coated tablets: Eltrombopagum 50 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Spirig HC 75 mg
28
k.A.
Coated tablets: Eltrombopagum 75 mg
Spirig HealthCare AG
A
FB
G
Eltrombopag Zentiva 12,5 mg
14
k.A.
Coated tablets: Eltrombopagum 12.5 mg
Helvepharm AG
A
FB
G
Eltrombopag Zentiva 25 mg
14
k.A.
Coated tablets: Eltrombopagum 25 mg
Helvepharm AG
A
FB
G
Eltrombopag Zentiva 25 mg
28
k.A.
Coated tablets: Eltrombopagum 25 mg
Helvepharm AG
A
FB
G
Eltrombopag Zentiva 50 mg
14
k.A.
Coated tablets: Eltrombopagum 50 mg
Helvepharm AG
A
FB
G
Eltrombopag Zentiva 50 mg
28
k.A.
Coated tablets: Eltrombopagum 50 mg
Helvepharm AG
A
FB
G
Eltrombopag Zentiva 75 mg
28
k.A.
Coated tablets: Eltrombopagum 75 mg
Helvepharm AG
A
FB
G
Eltrombopag NOBEL 12.5 mg
14
k.A.
Coated tablets: Eltrombopagum 12.5 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 25 mg
14
k.A.
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 25 mg
28
k.A.
Coated tablets: Eltrombopagum 25 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 50 mg
14
k.A.
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 50 mg
28
k.A.
Coated tablets: Eltrombopagum 50 mg
NOBEL Pharma Schweiz AG
A
FB
G
Eltrombopag NOBEL 75 mg
28
k.A.
Coated tablets: Eltrombopagum 75 mg
NOBEL Pharma Schweiz AG
A
FB
G
Emicizumab (B02BX06) 6 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
CI
Hemlibra 30mg/1ml
1628.05
1711.40
10 %
Injection solution: Emicizumabum 30 mg/ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 12mg/0.4ml
651.22
709.20
10 %
Injection solution: Emicizumabum 12mg / 0.4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 60mg/0.4ml
3256.09
3381.80
10 %
Injection solution: Emicizumabum 60mg / 0.4ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 105mg/0.7ml
5698.16
5887.35
10 %
Injection solution: Emicizumabum 105mg / 0.7ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 150mg/1ml
8140.23
8392.90
10 %
Injection solution: Emicizumabum 150 mg/ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Hemlibra 300mg/2ml
16280.46
16744.80
10 %
Injection solution: Emicizumabum 300mg / 2ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
Avatrombopag (B02BX08) 3 products
WHO-DDD
Page 1 of 3:
1
2
3
>>
L
IP
Doptelet 20 mg
10
620.37
691.10
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
15
930.56
1028.45
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
L
IP
Doptelet 20 mg
30
1861.11
2040.50
10 %
Coated tablets: Avatrombopagum 20 mg
Swedish Orphan
Biovitrum AG
A / SL
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
